Not recruiting
Obesity
Not recruitingInvestigational
A study to evaluate the efficacy and safety of zenagamtide in people with obesity
Investigational
- Disease:Obesity
- Substances:–
Countries:
The Netherlands
The Netherlands- Participants:18–64 years
Find therapies in clinical trials near you – page 8
- recruiting
- 3 961
- countries
- 28
- conditions
- 2 103
3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today
146 trials match your criteria
Not recruiting
Dementia Alzheimer's type
Not recruitingRegistered drug
Study of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
Registered drug
- Disease:Dementia Alzheimer's type
- Substances:Florbetaben (18F)Florbetapir (18F)+3
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Florbetaben (18F)
Not recruiting
Dementia Alzheimer's type
Not recruitingInvestigational
A study testing MK-1167 added to current treatment in patients with mild to moderate Alzheimer's disease dementia
Investigational
- Disease:Dementia Alzheimer's type
- Substances:Mk-1167
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Mk-1167
Not recruiting
Dementia Alzheimer's type
Not recruitingInvestigationalNo placebo
A Study to Test the Long-term Safety and Benefits of GSK4527226 in Patients with Early Alzheimer's Disease
InvestigationalNo placebo
- Disease:Dementia Alzheimer's type
- Substances:Gsk4527226
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Gsk4527226
Not recruiting
Acute myocardial infarction
Not recruitingInvestigational
A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
Investigational
- Disease:Acute myocardial infarction
- Substances:Ziltivekimab
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Ziltivekimab
Not recruiting
Prostate cancer
Not recruitingRegistered drugNo placebo
Study on Sildenafil and Vacuum Erection Device Therapy for Men with Prostate Cancer Undergoing Nerve-Sparing Surgery
Registered drugNo placebo
- Disease:Prostate cancer
- Substances:SildenafilPAPAVERINE HYDROCHLORIDE+1
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:Sildenafil
Not recruiting
Gastric cancer
Not recruitingRegistered drugNo placebo
Study on Treating Stomach Cancer with Peritoneal Spread Using Docetaxel and Oxaliplatin in Patients with Limited Peritoneal Carcinomatosis
Registered drugNo placebo
- Disease:Gastric cancer
- Substances:DocetaxelOxaliplatin
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Docetaxel
Not recruiting
Prostate cancer
Not recruitingRegistered drugNo placebo
Study on the Use of 18F-PSMA-1007, Piflufolastat (18F), and Gozetotide for Detecting Pelvic Lymph Node Invasion in Newly Diagnosed Prostate Cancer Patients
Registered drugNo placebo
- Disease:Prostate cancer
- Substances:GozetotidePiflufolastat (18F)+1
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Gozetotide
Not recruiting
Chronic obstructive pulmonary disease
Not recruitingRegistered drug
Study of Tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups
Registered drug
- Disease:Chronic obstructive pulmonary disease
- Substances:SalbutamolTozorakimab
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Salbutamol
Not recruiting
Breast cancer metastatic
Not recruitingRegistered drugNo placebo
Study comparing carboplatin-cyclophosphamide versus paclitaxel with atezolizumab as first treatment for advanced triple negative breast cancer
Registered drugNo placebo
- Disease:Breast cancer metastatic
- Substances:AtezolizumabBevacizumab+3
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Atezolizumab
Not recruiting
Chronic lymphocytic leukaemia
Not recruitingRegistered drugNo placebo
Study on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
Registered drugNo placebo
- Disease:Chronic lymphocytic leukaemia
- Substances:AcalabrutinibBendamustine+5
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Acalabrutinib
Not recruiting
Peripheral artery restenosis+4
Not recruitingRegistered drug
Study on the Effect of Clopidogrel and Acetylsalicylic Acid on Reducing Heart and Blood Vessel Events in Patients with Peripheral Arterial Disease
Registered drug
- Disease:Peripheral artery restenosisPeripheral artery angioplasty+3
- Substances:Acetylsalicylic AcidClopidogrel+1
Countries:The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Acetylsalicylic Acid